Key result
Mutating all five N-linked glycosylation sites within apoB-37 decreased secretion efficiency and association with lipoproteins by >50% compared with wild-type apoB-37.
N-glycans at the amino terminus of apoB play an important role in the assembly and secretion of lipoproteins containing carboxyl terminally truncated apoB.
Glycosylation modulates apoB secretion in vitro; leaves open whether it affects lipoprotein metabolism or offers therapeutic targets in humans.
We determined the role of N-linked glycosylation of apolipoprotein B (apoB) in the assembly and secretion of lipoproteins using transfected rat hepatoma McA-RH7777 cells expressing human apoB-17, apoB-37, and apoB-50, three apoB variants with different ability to recruit neutral lipids. Substituting Asn residue with Gln at the single glycosylation site within apoB-17 (N(158)) decreased its secretion efficiency to a level equivalent to that of wild-type apoB-17 treated with tunicamycin, but had little effect on its synthesis or intracellular distribution. When selective N-to-Q substitution was introduced at one or more of the five N-linked glycosylation sites within apoB-37 (N(158), N(956), N(1341), N(1350), and N(1496)), secretion efficiency of apoB-37 from transiently transfected cells was variably affected. When all five N-linked glycosylation sites were mutated within apoB-37, the secretion efficiency and association with lipoproteins were decreased by >50% as compared with wild-type apoB-37. Similarly, mutant apoB-50 with all of its N-linked glycosylation sites mutagenized showed decreased secretion efficiency and decreased lipoprotein association in both d < 1.02 and d > 1.02 g/ml fractions. The inability of mutant apoB-37 and apoB-50 to associate with very low-density lipoproteins was attributable to impaired assembly and was not due to the limitation of lipid availability. The decreased secretion of mutant apoB-17 and apoB-37 was not accompanied by accumulation within the cells, suggesting that the proportion of mutant apoB not secreted was rapidly degraded. However unlike apoB-17 or apoB-37, accumulation of mutant apoB-50 was observed within the endoplasmic reticulum and Golgi compartments. These data imply that the N-glycans at the amino terminus of apoB play an important role in the assembly and secretion of lipoproteins containing the carboxyl terminally truncated apoB.
No takes yet. Share an insight, caveat, or question.
Vukmirica et al. (2002) studied this question. N-to-Q substitution at N-linked glycosylation sites within apoB variants vs. Wild-type apoB variants was evaluated on Secretion efficiency and association with lipoproteins. Mutating all five N-linked glycosylation sites within apoB-37 decreased secretion efficiency and association with lipoproteins by >50% compared with wild-type apoB-37.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: